HopeStage
Back to all studies
CompletedNCT05472818

Brain imaging before and after cannabis abstinence in people with cannabis use disorder

About this titleRead the official source — NCT05472818
Medication studyAges 18–75United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 75 years.

Listed locations
New HavenSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 12, 2022
Recruitment status
Completed
Enrollment listed in the registry
51
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT05472818
Official title
Show the full official title

SV2A Density Cannabis Use Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Did this study involve medication?

Yes. The study involved medication, including [11C]APP311.

Who was this study for?

Listed age limits: 18 years to 75 years.

Want to explore more studies?

Explore studies